Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
0.737
+0.007 (1.01%)
At close: Apr 28, 2026, 4:00 PM EDT
0.715
-0.022 (-3.02%)
Pre-market: Apr 29, 2026, 5:31 AM EDT
Clearmind Medicine Cash Flow Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jan '26 Jan 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| Net Income | -6.64 | -3.86 | -5.25 | -8.62 | -6.89 | -3 | |
| Depreciation & Amortization | 0.05 | 0.05 | 0.05 | 0.06 | 0.08 | 0.01 | |
| Loss (Gain) From Sale of Investments | -0.34 | -0.84 | 0.07 | 0.11 | 0.31 | - | |
| Stock-Based Compensation | 1.84 | 0.81 | 1 | 0.83 | 1.21 | 0.68 | |
| Other Operating Activities | -0.66 | -0.85 | -0.59 | 2.29 | 0.33 | - | |
| Change in Accounts Receivable | -0.04 | 0.02 | 0.06 | -0.15 | 0.02 | -0.13 | |
| Change in Accounts Payable | 0.19 | 0.08 | -0.2 | -0.62 | 0.91 | 0.28 | |
| Change in Other Net Operating Assets | 0.05 | -0.14 | 0 | -0.19 | 0.3 | -0.13 | |
| Operating Cash Flow | -5.55 | -4.73 | -4.86 | -6.3 | -3.72 | -2.29 | |
| Capital Expenditures | - | - | - | - | -0.01 | -0.03 | |
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.16 | |
| Investment in Securities | -0.61 | -0.53 | -0.27 | - | - | - | |
| Other Investing Activities | - | -0.01 | 0.03 | -0.03 | - | -0.02 | |
| Investing Cash Flow | -0.61 | -0.54 | -0.24 | -0.03 | -0.01 | -0.2 | |
| Long-Term Debt Issued | - | 2.25 | - | - | - | - | |
| Long-Term Debt Repaid | - | -0.04 | -0.04 | -0.04 | -0.07 | - | |
| Net Debt Issued (Repaid) | 2.21 | 2.21 | -0.04 | -0.04 | -0.07 | - | |
| Issuance of Common Stock | 7.43 | 0.42 | 6.3 | 11.71 | 0.58 | 5.93 | |
| Financing Cash Flow | 9.63 | 2.62 | 6.25 | 11.66 | 0.51 | 5.93 | |
| Foreign Exchange Rate Adjustments | 0.01 | 0 | -0.01 | -0.04 | -0.02 | - | |
| Net Cash Flow | 3.48 | -2.65 | 1.15 | 5.3 | -3.24 | 3.44 | |
| Free Cash Flow | -5.55 | -4.73 | -4.86 | -6.3 | -3.73 | -2.31 | |
| Free Cash Flow Per Share | -14.26 | -37.25 | -62.69 | - | - | - | |
| Cash Interest Paid | 0 | 0 | 0.01 | 0 | 0.01 | - | |
| Cash Income Tax Paid | 0.25 | 0.23 | 0.31 | 0.01 | - | - | |
| Levered Free Cash Flow | -5.39 | -3.82 | -3.13 | -0.15 | -0.88 | -1.33 | |
| Unlevered Free Cash Flow | -5.38 | -3.81 | -3.11 | -0.14 | -0.87 | -1.33 | |
| Change in Working Capital | 0.2 | -0.04 | -0.13 | -0.97 | 1.24 | 0.02 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.